Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Plus Therapeutics(PSTV) the Revenue is 1.028 M (-2.93%);the EBIT is -7.119 M (-101.3%);the EPS is -1.05 (+96.5%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B2.93%
----
----
EBIT
-0.01B101.33%
----
----
EPS
-1.045196.50%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf